November 15, 2022. InnoTech Precision Medicine is one of the finalists for DxPx-Medica 2022 pitch competition in Dusseldorf Germany.
September 17, 2022. InnoTech Precision Medicine is the first place winner of EPPICON 2022 pitch competition at Santa Clara California.
September 12, 2022. Our IP attorneys Dr. Ashley Brzezinski and Mr. Chuck Larsen have moved to McDermott& Emery LLP and InnoTech Precision Medicines IP portfolio is transferred with them.
September 8, 2022. InnoTech Precision Medicine and Wainamics Inc (Pleasanton, California) sign an agreement for development of InnoTech’s disease-specific microfluidic cartridge.
May 24, 2021: MassMEDIC Announces IGNITE 2021 Cohort
March 22, 2021: Dr. Carlos Aparacio joins InnoTech Precision Medicine as our Chief Operation Officer. He brings over 30 years of medical device and diagnostics product development and commercialization to our company.
March 1, 2021: InnoTech Precision Medicine and Massachusetts Institute of Technology sign a cooperative agreement including a licensing agreement.
March 1, 2021: Mr. Joe St.Germain joins our company as Outside Chief Financial Officer.